Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to 0.84.

  • GeneDx Holdings' Asset Utilization Ratio rose 25.39% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year increase of 25.39%. This contributed to the annual value of 0.73 for FY2024, which is 63.67% up from last year.
  • As of Q3 2025, GeneDx Holdings' Asset Utilization Ratio stood at 0.84, which was up 5.50% from 0.80 recorded in Q2 2025.
  • GeneDx Holdings' Asset Utilization Ratio's 5-year high stood at 1.08 during Q2 2021, with a 5-year trough of 0.26 in Q3 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.62 (2024), whereas its average is 0.62.
  • As far as peak fluctuations go, GeneDx Holdings' Asset Utilization Ratio tumbled by 75.68% in 2022, and later soared by 76.17% in 2023.
  • GeneDx Holdings' Asset Utilization Ratio (Quarterly) stood at 0.37 in 2021, then fell by 3.01% to 0.36 in 2022, then spiked by 36.26% to 0.48 in 2023, then spiked by 52.21% to 0.74 in 2024, then climbed by 25.39% to 0.84 in 2025.
  • Its Asset Utilization Ratio stands at 0.84 for Q3 2025, versus 0.80 for Q2 2025 and 0.76 for Q1 2025.